Dr. Subechha Gyawali, MD

Dr. Gyawali practices at North Shore University Hospital in West Islip, New York.

Dr. Gyawali's NPI, 1629429725, was assigned on June 29, 2016. Dr. Gyawali holds South Carolina license 81740.

Dr. Gyawali's primary practice is North Shore University Hospital, at 1000 Montauk Hwy, West Islip, NY 11795 in Suffolk County. The practice phone is (516) 876-6000.

Dr. Gyawali's primary practice is North Shore University Hospital in West Islip, New York. Dr. Gyawali is also affiliated with Select Specialty Hospital - Charleston. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Gyawali to 5 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gyawali practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gyawali's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Gyawali's licenses on file in 2 states: South Carolina and West Virginia.

CMS data shows 863 Medicare services from Dr. Gyawali across 4 procedure codes in 2024, for 340 Medicare patients. Medicare paid $73,072 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 340 Medicare patients who saw Dr. Gyawali in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gyawali's median patient age at 54, with 57% women.

In 2024, Dr. Gyawali wrote 309 Medicare Part D claims for 154 patients. 90% of them were for generic drugs. CMS names the drug for 101 of them, across 6 drugs with 11 or more claims each, at $1,429 in total drug cost. In 2023, CMS named 92 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Gyawali for performance year 2024, reported through an alternative payment model (APM). Dr. Gyawali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 15 general payments to Dr. Gyawali from 6 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $122.